Insider Transactions in Q1 2024 at Protagonist Therapeutics, Inc (PTGX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2024
|
Harold E Selick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,490
+18.82%
|
$6,490
$1.89 P/Share
|
|
Mar 01
2024
|
Asif Ali Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,248
-14.16%
|
$455,936
$32.28 P/Share
|
|
Mar 01
2024
|
Asif Ali Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+18.56%
|
$144,000
$12.17 P/Share
|
|
Mar 01
2024
|
William D. Waddill Director |
SELL
Open market or private sale
|
Direct |
12,975
-51.95%
|
$402,225
$31.34 P/Share
|
|
Mar 01
2024
|
William D. Waddill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,975
+34.19%
|
$77,850
$6.09 P/Share
|
|
Mar 01
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-4.96%
|
$930,000
$31.62 P/Share
|
|
Feb 29
2024
|
Asif Ali Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,939
-10.2%
|
$298,170
$30.81 P/Share
|
|
Feb 26
2024
|
Suneel Gupta Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,282
-2.28%
|
$124,178
$29.53 P/Share
|
|
Feb 26
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,915
-1.77%
|
$316,535
$29.53 P/Share
|
|
Feb 15
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,717
-0.6%
|
$104,076
$28.23 P/Share
|
|
Jan 16
2024
|
Asif Ali Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,452
-2.79%
|
$34,848
$24.63 P/Share
|
|
Jan 16
2024
|
Arturo Md Molina Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-0.88%
|
$10,248
$24.63 P/Share
|
|
Jan 09
2024
|
Suneel Gupta Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.6%
|
$125,000
$25.0 P/Share
|
|
Jan 09
2024
|
Suneel Gupta Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.53%
|
$35,000
$7.38 P/Share
|
|
Jan 02
2024
|
Suneel Gupta Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,250
+9.31%
|
-
|
|
Jan 02
2024
|
Dinesh V Ph D Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
84,875
+12.05%
|
-
|
|
Jan 02
2024
|
Asif Ali Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+28.75%
|
-
|
|
Jan 02
2024
|
Arturo Md Molina Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+34.99%
|
-
|